ArticleInternational journal of general medicine2023

A Retrospective Study of Anlotinib Combined with Anti-PD-1 Inhibitors in the 2nd or Later-Line Treatment of Advanced Solid Tumors.

Shu-Hui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.